Spero Therapeutics, Inc.

SPRO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Oct 10, 2023 4
4 Oct 10, 2023 4
4 Oct 10, 2023 4
4 Oct 10, 2023 4
4 Oct 10, 2023 4
4 Oct 10, 2023 4
4 Oct 10, 2023 4
8-K Oct 10, 2023 8-K
4 Sep 15, 2023 4
ARS Sep 1, 2023 ARS
DEF 14A Sep 1, 2023 DEF 14A
4 Aug 30, 2023 4
4 Aug 30, 2023 4
4 Aug 30, 2023 4
4 Aug 30, 2023 4
144 Aug 29, 2023
PRE 14A Aug 22, 2023 PRE 14A
S-8 Aug 10, 2023 S-8
8-K Aug 10, 2023 8-K
10-Q Aug 10, 2023 10-Q
4 Aug 3, 2023 4
8-K Jul 31, 2023 8-K
3 Jul 24, 2023 3
4 Jun 14, 2023 4
8-K Jun 14, 2023 8-K
← Newer Page 6 of 21 · 513 filings Older →